Opioid Epidemic
Blog Post
Six Policy Changes to Keep Children Safe from Opioid Overdose
Pediatricians’ Suggestions for Health Care Providers, Institutions, and Policymakers

When someone is prescribed opioids, evidence shows that co-prescribing or offering naloxone to quickly reverse overdoses is associated with fewer deaths. However, even though the U.S. Food and Drug Administration (FDA) has approved it for children, policy and practice has rarely reflected the specific needs of children and families. This puts children at avoidable risk.
LDI Fellow Barbara H. Chaiyachati and colleagues believe it is time to more deeply consider the unique needs of children and families for naloxone access. Across the country, requirements vary for discussing, offering, or prescribing this overdose-reversal drug. Many regulations primarily focus on prescriber behavior, though some states allow pharmacy-level intervention. Even in the 18 states with mandates in 2023 for co-prescribing naloxone with opioids, legislation does not always consider children. For example, the required opioid dose for naloxone co-prescription can range from more than 50 morphine milligram equivalents (MME) per day to over 120 MME per day. The full range is well above the level of toxicity for many small children.
The researchers have published guidelines for parents and recommend that health care providers, institutions, and policymakers consider the following actions to keep children safe from overdose.
Health Care Providers
1. Increase communication about medication safety
Proactively discuss medication safety and opioid reversal with patients and let them know that naloxone is available over the counter.
2. Provide guidance on administering naloxone
When prescribing opioids, discuss naloxone and how to use it.
Health Care Institutions
3. Create guidelines for clinical interactions
Standardize how to discuss, offer, or prescribe naloxone in qualifying patients including children and adults who are frequently around children.
4. Codify naloxone co-prescribing
Consider including naloxone in professional society opioid prescribing guidelines such as reflected in the 2024 American Academy of Pediatrics (AAP) opioid prescribing clinical practice guideline.
Policymakers
5. Ease naloxone prescribing regulations
In regulations, consider removing dosing ranges or other qualifying circumstances or uncoupling them from risk criteria in children.
6. Follow U.S. Center for Disease Control and Prevention (CDC) guidance in policy
Consider including more family structures in legislation, such as those consistent with 2022 CDC guidance.
The viewpoint “Consideration of Children in Naloxone Coprescribing Laws” was published on November 24, 2024 in JAMA Pediatrics. Authors include Ava Hunt, Jeanette Trella, and Barbara H. Chaiyachati.
Author

Christine Weeks
Director of Strategic Initiatives
More on the Opioid Epidemic

Opioid Disposal Kits May Help Patients Dispose of Unneeded Painkillers
Pain Is Hard to Predict, and a Cheap Disposal Kit Offers a Solution

Chart of the Day: State Variation in Private Equity Ownership in Mental Health and Substance Use Disorder Facilities
New Geographic Trends Raise Questions About the Future of Behavioral Health Services

This Telehealth System Could Be Scaled Up Statewide To Treat Opioid Use Disorder
This Model Is Cheaper And Easier To Use Than The ER, LDI Fellow Argues In New Op-Ed

Fears of Family Separation Deter Parents With Substance Use Disorder From Getting Needed Care
Policymakers Should Consider Reporting and Planning Procedures That Do Not Involve Child Protective Services

Naloxone Access Improved in New York City in High Overdose Areas, But Gaps Remain Across the Five Boroughs
New Maps From LDI Researchers Show Progress in Locating Programs Where the Need Is Greatest